Indazole Derivatives as Emerging Scaffolds for Anti‐Breast Cancer Therapy: Synthesis, Structure–Activity Relationship, and Therapeutic Potential
Archiv der Pharmazie · 2026-11 · 359 (11)
DOI: 10.1002/ardp.70374 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archiv der Pharmazie, online erschienen am 29.10.2026. Verfasst von Soubhik Tanti und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Bathinda, India. Hauptthemen laut MEDLINE: Breast Neoplasms, Antineoplastic Agents, Indazoles. Die Arbeit nennt 104 Literaturangaben. Gefördert von: Anusandhan National Research Foundation (ANRF) under the Partnerships for Accelerated Innovation and Research (PAIR) programme.
Abstract (Originalsprache)
Breast cancer (BC) is the second most common cause of death in women. Current therapies like hormonal therapy, surgery, radiotherapy, and chemotherapy become ineffective due to severe side effects and multidrug resistance. Therefore, there is an urgent need for the development of more effective and safer anti‐BC agents. Among different classes of heterocyclic molecules, indazole‐based derivatives have emerged as potent anti‐BC agents due to their versatile structural features and wide range of biological targets. Indazole is a benzene‐pyrazole fused system with potential biological therapeutic significance. This review provides a detailed overview of recent progress in strategies that have expanded the accessible structural diversity of this scaffold. Moreover, mechanistic insights reveal that indazole derivatives mediate their antitumor effects through multi‐target modulation, including the inhibition of key kinases such as EGFR, VEGFR, and CDKs, perturbation of microtubule function, activation of apoptotic pathways, and modulation of hormone receptor‐dependent signalling, along with SAR. Collectively, this article is a BC‐focused integration of different synthetic approaches, the key molecular targets for therapy, and studies showing which groups are responsible for their anti‐BC potential, focusing on the latest research published.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Bathinda, India.
ORCID-Profile: Soubhik Tanti, Akhilesh Gangwar, Vikas Jaitak
Förderung
- Anusandhan National Research Foundation (ANRF) under the Partnerships for Accelerated Innovation and Research (PAIR) programme
Zitieren
APA
Tanti, S., Gangwar, A., & Jaitak, V. (2026). Indazole Derivatives as Emerging Scaffolds for Anti‐Breast Cancer Therapy: Synthesis, Structure–Activity Relationship, and Therapeutic Potential. Archiv der Pharmazie, 359(11). https://doi.org/10.1002/ardp.70374
Vancouver
Tanti S, Gangwar A, Jaitak V. Indazole Derivatives as Emerging Scaffolds for Anti‐Breast Cancer Therapy: Synthesis, Structure–Activity Relationship, and Therapeutic Potential. Archiv der Pharmazie. 2026;359(11). doi:10.1002/ardp.70374
BibTeX
@article{Tanti2026,
author = {Tanti, Soubhik and Gangwar, Akhilesh and Jaitak, Vikas},
title = {Indazole Derivatives as Emerging Scaffolds for Anti‐Breast Cancer Therapy: Synthesis, Structure–Activity Relationship, and Therapeutic Potential},
journal = {Archiv der Pharmazie},
year = {2026},
volume = {359},
number = {11},
doi = {10.1002/ardp.70374}
}
EUVIMED